timing of RT in metastatic NSCLC in conjunction with immunotherapy.

Published Date: 15 Apr 2023

According to a new study, patients with metastatic non-small cell lung cancer who receive radiotherapy and immunotherapy within 1–12 months—but not earlier or later—may have a higher chance of surviving without relapse.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot